Picture courtesy uk.news.yahoo.com
New Delhi: The central government’s Subject Expert Committee (SEC) is likely to meet on Wednesday on drugmaker Dr. Reddy’s application seeking emergency use authorisation for the Sputnik V vaccine in India. If the SEC gives a nod, Sputnik V will be India’s third vaccine after Covaxin and Covishield, News18 reported.
Dr. Reddy’s has partnered with the Sputnik V vaccine to run clinical trials in India. It had submitted the immunogenicity data after a meeting that was held on February 24.
Dr Reddy’s has partnered with Russia Direct Investment Fund (RDIF) to bring the Sputnik V vaccine to India. The Russian vaccine has shown an efficacy of 91.6 %.
New York: Ahead of Christmas, stranded NASA astronauts Sunita Williams and Butch Wilmore turned Santa…
Hyderabad: There’s no respite for BRS leader KT Rama Rao (KTR) in the case linked…
Sambalpur: The Indian Institute of Management (IIM) at Sambalpur in Odisha has announced changes in…
Mumbai: Arjun Kapoor, who broke up with girlfriend Malaika Arora, impressed movie buffs and critics…
Mumbai: ‘Citadel: Honey Bunny’ actor Varun Dhawan, who has been in the industry for a…
New Delhi: Delhi Police on Friday transferred the FIR filed against Congress leader Rahul Gandhi…
This website uses cookies.